Seong-Wook Seo, MD
Pain Medicine · Bolivar, MONPI 1104213180
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (45.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Boston Scientific at 36.5% of the total. Reporting peaked in 2019 at $6,915 and has fallen 84.7% since, to $1,060 in 2025.
Across 117 payments — averaging $116.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$5K
- Medtronic$4K
- Abbott$2K
- Nevro Corp.$965
- Stryker$831
- AbbVie$304
- plus $504 from 7 others
What the payments were for
- Grants$6,25046%
- Travel & lodging$4,68034%
- Food & beverage$2,75520%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 21 | $5,000 |
| Medtronic(2 entities) | 8 | $4,408 |
| Abbott | 30 | $1,673 |
| Nevro Corp. | 17 | $965 |
| Stryker | 4 | $831 |
| AbbVie(2 entities) | 15 | $304 |
| Vertos Medical, Inc. | 4 | $123 |
| Collegium Pharmaceutical, Inc. | 7 | $121 |
| Globus Medical | 4 | $106 |
| SPR Therapeutics, Inc | 2 | $58 |
| Averitas Pharma Inc. | 2 | $40 |
| Vertex | 2 | $39 |
| MML US, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMED$3,750
- SPECTRA WAVEWRITER$2,500
- PROCLAIM$1,077
- Intracept$809
- SPINEJACK$788
- Senza Spinal Cord Stimulation System$536
- RESTORE$519
- WAVEWRITER ALPHA$250
How this compares
$13,685 in reported general payments places this provider in the 85th percentile of 124 pain medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 11 | $6,550 |
| MovantikNaloxegol Oxalate | 12 | $4,981 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 322 | $4,903 |
| Pregabalin | 68 | $3,044 |
| Buprenorphine | 23 | $2,895 |
| Hydromorphone Hcl | 37 | $2,144 |
| Oxycodone Hcl | 117 | $1,958 |
| Morphine Sulfate ErMorphine Sulfate | 35 | $1,530 |
| Tramadol Hcl | 225 | $1,141 |
| Tizanidine Hcl | 122 | $933 |
| Methocarbamol | 83 | $905 |
| Celecoxib | 54 | $724 |
| Gabapentin | 51 | $484 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 21 | $446 |
| Baclofen | 16 | $270 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Bolivar
- Christopher ReisCape Girardeau$113K
- Anne ChristopherChesterfield$104K
- Tyler ConcannonKansas City$64K
- Vinicius Tieppo FrancioSaint Louis$35K
- Luvell GlantonHannibal$33K
- Jooyoung MaengSaint Louis$25K
- Travis FoxxLiberty$23K
- Nabil AhmadSaint Louis$21K
- Chad SheltonSaint Peters$18K
- Katharine GurbaSaint Louis$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.